Biological Effects of Phosphate on Fibroblast-Like Synoviocytes. (14th February 2012)

• Record Type: Journal Article
• Authors: Sun, Yubo; Mauerhan, David R.; Chaturvedi, Deepthi; Hanley, Edward N.; Gruber, Helen E.
• Other Names: Chiarini A. Academic Editor.
• Is Part Of: ISRN cell biology. Volume 2012(2012)
• Publication Date: 2012-02-14
• Subjects: Cytology -- Periodicals; Cells; Cell Biology; Cells; Cytological Techniques; Biology; Cells; Cytology; Periodicals; Electronic journals; 571.6
• DOI: 10.5402/2012/295341
• Languages: English
• ISSNs: 2090-7370

Abstract

Abstract : This study sought to examine the expression of genes implicated in phosphate transport and pathological calcification in osteoarthritis (OA) and rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) and investigate the biological effects of phosphate. Results revealed that several genes, which were implicated in phosphate transport and pathological calcification, were differentially expressed in OA FLS and RA FLS. Phosphate stimulated the expression of matrix metalloproteinse-1, matrix metalloproteinse-3, cyclooxygenase-2, and interleukin-1 β in a dose-dependent manner. Phosphate also induced OA FLS cell death but not RA FLS cell death at higher concentration. Calcification inhibitors, phosphocitrate (PC), and ethane-1-hydroxy-1, 1-diphosphonate (EHDP), effectively inhibited these detrimental biological effects of phosphate. These findings suggest that abnormal expression of genes implicated in phosphate transport and pathological calcification may contribute to the progression of OA through the induction of extracellular matrix-degrading enzymes, proinflammatory cytokines, cell death, and calcium deposits. Calcification inhibitors such as PC and EHDP are potent inhibitors of these detrimental biological effects of phosphate.